Device
The imaging biomarkers determined by MR-PET
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Other(4)
Detailed Status
unknown4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
N/A
Trials by Status
unknown4100%
Recent Activity
0 active trials
Showing 4 of 4
unknown
MR/PET in the Evaluation of Patients With Esophageal Cancer
NCT02547610
unknown
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
NCT02550613
unknown
Application of MR-PET in Colorectal Cancer
NCT02553031
unknown
Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer
NCT02550847
Clinical Trials (4)
Showing 4 of 4 trials
NCT02547610
MR/PET in the Evaluation of Patients With Esophageal Cancer
NCT02550613
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
NCT02553031
Application of MR-PET in Colorectal Cancer
NCT02550847
Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4